Abstract
Keywords
References
1.
Bergenstal
RM
Tamborlane
WV
Ahmann
A
Buse
JB
Dailey
G
Davis
SN
Joyce
C
Peoples
T
Perkins
BA
Welsh
JB
Willi
SM
Wood
MA
; STAR 2 Study Group . Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes . N Engl J Med.
2010 ;363 (4 ): 311 –20 . Epub 2010 Jun 29.
2.
Hermanides
J
Nørgaard
K
Bruttomesso
D
Mathieu
C
Frid
A
Dayan
CM
Diem
P
Fermon
C
Wentholt
IM
Hoekstra
JB
DeVries
JH
. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial . Diabet Med.
2011 ;28 (10 ): 1158 –67 . doi: 10.1111/j.1464-5491.2011.03256.x.
3.
Pickup
JC
Freeman
SC
Sutton
AJ
. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: Meta-analysis of randomised controlled trials using individual patient data . BMJ.
2011 ;343 : d3805 . doi: 10.1136/bmj.d3805.
4.Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group ,
Beck
RW
Buckingham
B
Miller
K
Wolpert
H
Xing
D
Block
JM
Chase
HP
Hirsch
I
Kollman
C
Laffel
L
Lawrence
JM
Milaszewski
K
Ruedy
KJ
Tamborlane
WV
. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes . Diabetes Care.
2009 ;32 (11 ): 1947 –53 . Epub 2009 Aug 12.
5.
Ramchandani
N
Arya
S
Ten
S
Bhandari
S
. Real-life utilization of real-time continuous glucose monitoring: The complete picture . J Diabetes Sci Technol.
2011 ;5 (4 ): 860 –70 .
6.
Ritholz
MD
Atakov-Castillo
A
Beste
M
Beverly
EA
Leighton
A
Weinger
K
Wolpert
H
. Psychosocial factors associated with use of continuous glucose monitoring . Diabet Med.
2010 ;27 (9 ): 1060 –5 .